baber/WOPTO huggingface dataset:
Patent NZ-250408-A (NZ)
Title: Phenylthioacetamide derivatives and pesticidal compositions
Inventor: WINGERT HORST
IPC: C07D215/20
Filed: 1993-12-10
Abstract: Thioamides of the general formula I <IMAGE>  in which     A, B and R' are hydrogen, cyano, alkyl, alkoxy or halogen,   X denotes =CHCH3 or =N-OCH3,   R<1> and R<2> denote hydrogen or alkyl,   Y denotes the group -O-, -S-, <IMAGE> -O-CH2, -CH2-O-, -S-CH2-, -CH2-S-, -CH2-CH2, -CH=CH-, -C IDENTICAL C-, -CH2-O-N IDENTICAL C(R')- and R denotes hydrogen, optionally substituted alkyl, optionally substituted cycloalkyl, optionally substituted aryl or optionally substituted hetaryl, and pesticides containing these compounds.,
Patent NZ-279397-A (NZ)
Title: Mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives and pharmaceutucal compositions
Inventor: FLYNN GARY ALAN
IPC: C07K1/06
Filed: 1995-01-09
Abstract: The present invention relates to certain novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo[c]azepin-3-one disulfide derivatives of the formula   <IMAGE>   useful as inhibitors of enkephalinase and of ACE.
Patent NZ-295492-A (NZ)
Title: Storage stable aqueous infusion for iv administration comprising a thrombin inhibitor
Inventor: STJERNFELT ULLA
IPC: C07K5/02
Filed: 1995-10-19
Abstract: PCT No. PCT/SE95/01228 Sec. 371 Date Dec. 18, 1995 Sec. 102(e) Date Dec. 18, 1995 PCT Filed Oct. 19, 1995 PCT Pub. No. WO95/14084 PCT Pub. Date May 17, 1996This invention relates to a storage stable concentrated water-solution for infusion having a pH in the range from 1.0 to 2.5 and containing an active thrombin inhibitor having the formulaHOOC-CH2-Ywherein Y is (R)-Cha-Pic-Nag or (R)-Cgl-Aze-Pab, as a salt or as a free base thereof, a process for their preparation and to a method for treatment of a patient in need of said formulation.
Patent NZ-295655-A (NZ)
Title: Microemulsion preconcentrate containing sparingly soluble active agent and a carrier containing a hydrophillic phase, a lipophilic phase and a surfactant
Inventor: COTTENS SYLVAIN
IPC: A61K31/435
Filed: 1995-10-25
Abstract: This invention provides a microemulsion pre-concentrate comprising a difficultly soluble agent and a carrier medium comprising: 1) a hydrophilic phase which comprises dimethyisosorbide and/or a lower alkyl alkanoic ester, 2) a lipophilic phase, and 3) a surfactant. The active agent may be a cyclosporine or a macrolide. In another aspect, this invention provides a pharmaceutical composition for enteral or parenteral administration comprising a macrolide and an acid.
Patent NZ-301424-A (NZ)
Title: Manufacture of coated tablet with two functionally different layers one being a core material containing a proton pump inhibitor
Inventor: LUNDBERG PER JOHAN
IPC: A61K9/22
Filed: 1996-02-09
Abstract: A new oral pharmaceutical dosage form comprising a core material that contains a proton pump inhibitor, one or more alkaline reacting compounds and optionally pharmaceutical excipients having a water soluble separating layer and an enteric coating layer. The core material as such is alkaline reacting and the separating layer between the alkaline reacting core material and the enteric coating layer is formed in situ as a water soluble salt between the alkaline reacting compound(s) and the enteric coating polymer. The invention also describes a new efficient process for the manufacture of such a dosage form comprising two functionally different layers in one manufacturing step, and its use in medicine. <IMAGE>
Patent NZ-319994-A (NZ)
Title: Lawsonia intracellularis cultivation, anti-lawsonia intracellularis vaccines and diagnostic agents
Inventor: KNITTEL JEFFREY P
IPC: C12N5/071
Filed: 1996-06-05
Abstract: method for large scale cultivation and attenuation of Lawsonia intracellularis bacteria by inoculating cells with L. intracellularis bacteria to infect the cells, incubating the infected cells in a reduced oxygen concentration and maintaining the infected cells in suspension. Anti-L. intracellularis vaccines are prepared from cultures grown in suspension. Diagnostic agents are also disclosed.
Patent NZ-325633-A (NZ)
Title: Registering of continuously moving layers comprises sensing reference marks and measuring the distance between two reference mark signals
Inventor: CHAPDELAINE LOUIS MAURICE
IPC: B65H39/16
Filed: 1996-12-11
Abstract: A process for controllably registering two continuously moving layers (54, 66) of material is provided. One of the layers (66) of material has a plurality of reference marks (74) representing a plurality of separate and distinct components, and the other of the continuously moving layers (54) has a respective plurality of different components thereon. The process controls the distance between reference marks to a selected distance, and controllably registers each reference mark to a respective component of the continuously moving second layer. An article is provided in which a graphic is controllably registered within a designated area thereof.
Patent NZ-326944-A (NZ)
Title: Capsule opening arrangement for use in a powder inhaler
Inventor: HORLIN ERNST
IPC: A61M15/00
Filed: 1997-01-27
Abstract: The invention relates to capsule opening arrangement for a powder inhaler device. The arrangement has a first part (4) and second part (5) which are relatively movable with respect to one another. The first part has a capsule supporting means (9) comprising an aperture (10) for supporting at least one severable capsule (11). The second part (5) contains a capsule severing means (14) fixedly located therein so as to pass across the supporting aperture (10) during relative movement of said parts (4, 5). The opening arrangement provides particular advantages in that the capsule (11), after severing, has a large open area from which powder can be extracted without any part of the capsule interfering with the powder flow.
Patent NZ-333452-A (NZ)
Title: Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone using functional barrier
Inventor: HUNZIKER ERNST B
IPC: A61F2/30
Filed: 1997-06-24
Abstract: A method for treating full thickness defects in cartilage in non-human animals which comprises: filling the cartilage portion of the defect with a matrix containing an effective amount of an anti-angiogenic agent like suramin to prevent ingrowth of blood vessels into the cartilage. This can further contain a transforming factor to transform repair cells into chondrocytes selected from TGF-b and BMP, proliferation agent to stimulate proliferation of repair cells.
Patent NZ-333779-A (NZ)
Title: Polyvalent avian vaccine comprising at least three plasmids integrating a pathogen gene
Inventor: AUDONNET JEAN-CHRISTOPHE
IPC: A61K39/295
Filed: 1997-07-16
Abstract: An avian vaccine formula including at least three polynucleotide vaccine valencies that each include a plasmid containing an avian pathogen gene capable of being expressed in vivo in host cells. The plasmids include one or more genes per valency.  The genes are selected from the group consisting of;  gB and gD for Marek's disease virus;  HN and F for Newcastle disease virus;  VP2 for infectious bursal disease virus;  S, M and N for infectious bronchitis virus; and  C + NS1 for infectious anaemia virus. The vaccine formula can be used as a booster for a first avian vaccine.
Patent NZ-336758-A (NZ)
Title: Supporting frame with assemblage nodes and braces
Inventor: LEITNER BURKHARDT
IPC: F16B1/00
Filed: 1997-12-16
Abstract: A supporting frame is disclosed with assemblage nodes and braces, which is characterized in that the joint between the assemblage nodes (3) and the end parts of the braces (5) comprises a pin joint, that at least one of the elements (braces (5)) of the pin joint (11) which can be plugged into each other has at least one magnet  and that at least a partial area of the corresponding counter-part (pin (13)) is ferromagnetic.
Patent NZ-502243-A (NZ)
Title: Wind energy installation with measuring apparatus on rotor hub to determine instantaneous mechanical load
Inventor: WOBBEN ALOYS
IPC: F03D7/02
Filed: 1998-06-20
Abstract: A wind energy installation has a rotor with at least one blade for the conversion of wind flow energy into mechanical energy, a regulating device for individual regulation of at least one rotor blade, a generator for the conversion of mechanical energy provided by the rotor into electric power, and an active connection between the rotor and the generator so that the mechanical energy can be transferred from the rotor to generator. The aim of the invention is to avoid such problems as those mentioned in the description and to provide a wind installation whereby the loads which can occur in partial areas of the surface of the rotor as a result of local transitory peaks in wind speeds are reduced. This is achieved by providing the above-mentioned wind energy installation with means of measurement such as an anemometer (44) placed on each rotor blade to determine the momentary load of one part of the wind energy installation, in addition to control means which determine a desired position for at least one rotor blade in order to react to said momentary load and to adjust the rotor blade accordingly using the regulating device, as well as joints and fasteners which connect the regulating device and means of measurement to the control means.
Patent NZ-502863-A (NZ)
Title: Joining of cladding system gaskets at mitred corners using injection moulded plug
Inventor: REYNOLDS DONALD ARTHUR
IPC: B29C45/14
Filed: 1998-09-16
Abstract: A joint (32) between two plastics extrusions (10) is formed by mitring the extrusions (10) so that they form the desired angle to one another, removing part of the rear face of each extrusion (10), placing the mitred extrusions in a mould and injecting a resin material whereby to bond the extrusions (10) to one another and produce the desired joint (32) configuration. Because the front surface (24) of the joint is entirely made up from the original extrusions, there are no problems with raised sight-lines, colour differentials, surface differences, or colour matching. A corner can be produced which has a clean right angled rather than radiused inner portion.
Patent NZ-512464-A (NZ)
Title: Method and apparatus for introducing in continuous a substance in liquid phase into plastics granules
Inventor: COLOMBO GIUSEPPE
IPC: B01F13/10
Filed: 1999-12-20
Abstract: A method and an apparatus for introducing in continuous a substance in liquid phase into plastics granules by means of the steps of: a) feeding a substantially continuous flow of the plastics granules to at least one substantially static spraying chamber (40, 29); b) spraying the substance in liquid phase onto the plastics granules continuously flowing within the spraying chamber (40, 29); c) submitting to mixing the granules partially or totally coated by the substance in liquid phase, continuously leaving the spraying chamber (40, 29), by means of substantially static mixing means (6) supported within a mixing zone (5) provided downstream of the spraying chamber (40, 29) and comprising at least one mixing chamber (5a, 5b); d) submitting the granules so obtained to drying for a time sufficient to allow a substantially complete absorption of the substance in liquid phase by the granules.  This allows the continuous impregnation of plastics granules, minimising the abrasive action on the granules themselves and hence minimising the generation of plastics dust.
Patent NZ-514301-A (NZ)
Title: Antiperspirant compositions
Inventor: ESSER ISABELLE CLAIRE HELENE M
IPC: A61K8/92
Filed: 2000-03-31
Abstract: A structured emulsion antiperspirant composition containing 15-75% wt of a continuous phase having a water- immiscible liquid carrier and a gel-forming structurant, 25- 85%wt of a disperse phase which is a solution of the antiperspirant active in water, wherein the structurant has a molecular weight of less than 10000 and provides a network of fibres in the liquid carrier and is present from 1-20% wt.
Patent NZ-516239-A (NZ)
Title: Use of cortisol antagonists in the treatment for heart failure
Inventor: MARIN PER
IPC: A61K31/417
Filed: 2000-07-03
Abstract: Disclosed herein is the use of a cortisol antagonist in the manufacture of a medicament for the treatment of heart failure, and a product containing (a) a cortisol antagonist and (b) a second drug as a combined preparation for simultaneous, separate or sequential use in the treatment of heart failure or in improving cardiac function and reducing exercise intolerance.
Patent NZ-517579-A (NZ)
Title: Methods of and compositions for inhibiting the proliferation of mammalian cells
Inventor: ROIZ LEVAVA
IPC: C12N9/22
Filed: 2000-08-29
Abstract: The use of a therapeutically effective amount of a ribonuclease of the T2 family (T2 RNase) having actin binding activity, such as RNase B1, for the manufacture of a medicament for preventing, inhibiting and/or reversing proliferation, colonization, differentiation and/or development of abnormally proliferating cells in a subject; wherein the abnormally proliferating cells may be cells associated with a proliferative disorder or disease selected from papilloma, blastoglioma, Kaposi's sarcoma, melanoma, lung cancer, ovarian cancer, prostate cancer, squamous cell carcinoma, astrocytoma, head cancer, neck cancer, bladder cancer, breast cancer, colorectal cancer, thyroid cancer, pancreatic cancer, gastric cancer, hepatocellular carcinoma, leukemia, lymphoma, Hodgkin's disease, Burkitt's disease, arthritis, rheumatoid arthritis, diabetic retinopathy, angiogenesis, restenosis, in-stent restenosis and vascular graft restenosis.
Patent NZ-518395-A (NZ)
Title: Process for the hydrogenation of hop resin acids
Inventor: SMITH ROBERT J
IPC: A23L35/00
Filed: 1999-11-18
Abstract: The application discloses a process for the hydrogenation of fluidized hop resin acids in their naturally acidic state. The process comprises contacting the said hop resin acids with hydrogen gas in the presence of a noble metal catalyst, and in the absence of liquid, organic solvents.
Patent NZ-522718-A (NZ)
Title: Lignocellulosic composites
Inventor: LLOYD JEFFREY D
IPC: A01N59/14
Filed: 2001-05-14
Abstract: A method for forming lignocellulosic-based composite products which are resistant to insect and fungal attack, which method comprises incorporating a pesticidal amount of a calcium borate, such as calcium polytriborate, calcium hexaborate, calcium metaborate, calcium sodium borate or calcium magnesium borate, prior to forming the composite product. The lignocellulosic material may be selected from wood, flax, hemp, jute, bagasse or straw.
Patent NZ-525166-A (NZ)
Title: Pharmaceutical non-aqueous solutions of modafinil compounds
Inventor: JACOBS MARTIN J
IPC: A61P25/28
Filed: 2001-10-11
Abstract: A pharmaceutical composition comprising a modifinil compound in solution, preferably the modifinil compound is either modifinil or the levorotary form of modifinil; and the use of a modifinil solution in the preparation of a medicament, optionally a non-aqueous medicament, for treating a disease or disorder selected from the group comprising sleepiness, tiredness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, attention deficit hyperactivity disorder, cognitive dysfunction and fatigue, or for the promotion of wakefulness, stimulation of appetites or stimulation of weight gain.
Patent NZ-533054-A (NZ)
Title: Pharmaceutical combinations of adenosine A-2A and beta-2-adrenergic receptor agonists
Inventor: YEADON MICHAEL
IPC: C07H19/16
Filed: 2002-11-28
Abstract: Disclosed is an inhaled combination of an adenosine A2a receptor agonist of formula (I) wherein the substituents are as described in the specification; and an adrenergic beta-2 receptor agonist. Combinations of the type disclosed are useful in the treatment of obstructive airway diseases or other inflammatory diseases.
Patent NZ-533950-A (NZ)
Title: A system for controlling a physical task
Inventor: LEGGE JENNY
IPC: A61B5/11
Filed: 2002-12-02
Abstract: A system for controlling physical activity for a person that comprises: (a) A plurality of task files each having data relating to physical task requirements for a person performing a type of task, and a plurality of frequency requirements that indicate a frequency for performing at least one physical task for the type of task file; and (b) A plurality of personal data files for persons' including data relating to allowable physical tasks and allowable frequency limits for each person when performing the at least one physical task wherein; One personal data file having a selected person's allowable frequency limits data is compared with a task file having data relating to a physical task requirements of the task type and from the comparison an indication is produced of whether the selected person is able to safely perform one or more physical tasks in the task file.
Patent NZ-535398-A (NZ)
Title: Test of visual search
Inventor: HARDWICK INNES CARRIE RUTH
IPC: G09B9/052
Filed: 2004-09-17
Abstract: A computerized test method for visual search speed and accuracy includes showing the test subject a series of different test screens. Each test screens contains a plurality of stimuli which include a target stimulus. The test subject is required to react in a specified manner to the target stimuli. The position of the target stimulus relative to the other stimuli is varied at random in the different test screens. Each test screen is shown to the test subject for a specified period. The specified reaction required from the subject may be instinctive or non-instinctive.
Patent NZ-535703-A (NZ)
Title: Eductor
Inventor: HAGUE BARRY
IPC: B01F3/08
Filed: 2003-03-20
Abstract: An eductor (1) having an air gap (5), a venturi structure (3), and a non-return valve (19) located in the air gap (5). The non-return valve is removable and allows the eductor to be operated as an air gap eductor or a non-return valve eductor. A non-return valve cartridge (19) for installing in to the air gap (5) of an air gap eductor (1), so that the eductor can be operated as a non-return valve eductor. A method of retrofitting a non-return valve (19) in an air gap eductor (1).
Patent NZ-536689-A (NZ)
Title: Streptococcus salivarius strain and extract having anti-mutans Streptococci activity
Inventor: CHILCOTT CHRISTOPHER NORMAN
Filed: 2003-05-14
Abstract: Disclosed are a biologically pure culture of Streptococcus salivarius strain Mia and an extract obtained from that strain having anti-mutans Streptococci (MS) activity. Compositions containing the disclosed extract are useful in inhibiting the growth of bacteria and in particular the therapeutic treatment of dental caries.
Patent NZ-537858-A (NZ)
Title: Compounds, compositions, and methods employing same
Inventor: BAJJI ASHOK
IPC: A61K31/165
Filed: 2003-07-15
Abstract: Disclosed is a compound having the formula (I) or a pharmaceutically acceptable salt, ester, amid, hydrate or solvate thereof, wherein the substituents are defined in the specification. Also disclosed is the above compound for use in treating a neoplastic disease, an autoimmune disease, an osteoporotic disorder, a viral infection, keloid, liver cirrhosis or psoriasis.
Patent NZ-538942-A (NZ)
Title: 2-(6-methyl-pyridin-2-yl)-3-[6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole suitable for the treatment of cancer
Inventor: BEIGHT DOUGLAS WADE
IPC: A61K31/4709
Filed: 2003-11-10
Abstract: 2-(6-methyl-pyridin-2-yl)-3-[6-amido-quinolin-4-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazole of formula (II) and the pharmaceutically acceptable salts thereof that are suitable for the treatment of cancer are disclosed.
Patent NZ-540466-A (NZ)
Title: Imidazole derivatives having affinity for alpha 2 receptors activity
Inventor: JARVINEN TOMI
IPC: C07D233/54
Filed: 2003-12-05
Abstract: Disclosed is a compound of formula (I), wherein R represents unsubstituted or substituted lower alkyl, unsubstituted or substituted aryl, unsubstituted or substituted cycloalkyl, unsubstituted or substituted heteroaryl, unsubstituted or substituted lower alkylamino or a saturated five or six membered heterocyclic group containing one or two nitrogen atoms. The compounds are prodrugs of the alpha2 adrenergic agonist MPV-2426 or [4-(6-hydroxyindan-1-ylmethyl)-1H-imidazol-1-ium chloride, and are useful in the treatment of hypertension, glaucoma, migraine, diarrhea, ischemia, addiction to chemical substances, hypotension, shock, cardiopulmonary resuscitation, micturition disorders, withdrawal syndromes, congestive heart failure, anxiety or different neurological, musculoskeletal, psychiatric or cognition disorders or as a sedative or an analgesic agent, nasal decongestant or as an adjunct to anaesthesia.
Patent NZ-544631-A (NZ)
Title: Construction composition
Inventor: LUCAS CHRISTOPHER FRANCIS
Filed: 2006-01-11
Abstract: Disclosed is a composition for filing gaps between adjacent construction components including a resin, of a concentration between substantially 6 and 18% of the composition, expressed as the volume of the resin solids of the composition, a bulk particulate material, of a concentration between substantially 50 to 80% of the composition by volume, a calcium aluminate cement component, at a concentration between substantially 0.5 to 4 times the weight of the dry resin amount, and a liquid, at a concentration of between 10 and 30% of the composition by volume the composition characterised in that the calcium aluminate cement component is of a composition that does not release or cause the production of free lime, either during or after curing, wherein the composition does not include Ordinary Portland cement or free lime.
Patent NZ-548437-A (NZ)
Title: Improvements relating to locks
Inventor: BRYHN SIGURD GUSTAF
Filed: 2006-07-11
Abstract: A key K and lock 10 with a spacer element 14 attached to the plug of the lock are disclosed. The spacer element 14 cooperates with a shoulder S of a key K to enable that key to operate the lock. When the spacer element is detached from the plug, the key if inserted does not align properly with the lock. The system is disclosed to be particularly suited to locks with construction keying.
Patent NZ-548625-A (NZ)
Title: Telecommunications system indicator and protector
Inventor: KOTZE LEON
IPC: H04B3/46
Filed: 2004-12-17
Abstract: A telecommunications system indicator and protector for indicating the working status of a telecommunications line and of equipment which can be connected to the telecommunications line is disclosed. The telecommunications system indicator and protector includes connecting means whereby the telecommunications system indicator and protector can be connected to the telecommunications line and the equipment respectively; a line testing circuit; an equipment testing circuit including a lightning protector for protecting the equipment against lightning surges; a switch being movable between a first position wherein the telecommunications line is connected to the line testing circuit and a second position wherein the telecommunications line is connected to the equipment testing circuit; and an indicator for indicating whether the telecommunications line is in working order when the switch is located in the first position, and whether the equipment is in working order when the switch is located in the second position.
Patent NZ-552389-A (NZ)
Title: Statin pharmaceutical compositions and related methods of treatment
Inventor: GUZMAN HECTOR
Filed: 2005-08-05
Abstract: Provided is a pharmaceutical composition comprising a divalent pravastatin or fluvastatin salt and an omega-3 oil. Further provided are uses of the composition in the manufacture of medicaments to reduce cholesterol levels and treat cardiovascular diseases.
Patent NZ-553477-A (NZ)
Title: Liquid co-infusion device
Inventor: KITANI ICHIRO
Filed: 2007-02-27
Abstract: A liquid co-infusion device (A or B) having a plurality of connection ports (12, 13, 14), and an operating part (20) axially movable within a chamber (11) of the device so as to selectively connect or isolate one of said connection ports from said chamber. An end of the operating part may include a groove (21a) or through channel movable to cause such isolation. Preferably, the axial movement of said operating part is guided so as to include an axial movement stop.